Australia markets closed

Eloxx Pharmaceuticals, Inc. (ELOX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.9000+0.0623 (+7.44%)
At close: 03:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-41,836
-36,065
-66,727
-34,577
Depreciation & amortisation
719
695
960
571
Stock-based compensation
3,980
3,021
9,167
8,666
Change in working capital
387
-118
-32
-3,404
Accounts payable
-514
1,641
-320
-1,390
Other working capital
-36,201
-31,911
-35,090
-28,166
Other non-cash items
519
541
22,087
563
Net cash provided by operating activities
-36,115
-31,845
-35,001
-28,166
Cash flows from investing activities
Investments in property, plant and equipment
-40
-66
-89
-
Purchases of investments
-
-
0
0
Sales/maturities of investments
-
-
0
33,750
Other investing activities
-
-
-
42
Net cash used for investing activities
-86
-66
2,056
33,792
Cash flows from financing activities
Debt repayment
0
0
-11,383
-4,583
Common stock issued
0
0
47,718
0
Other financing activities
8,376
8,812
2,556
277
Net cash used provided by (used for) financing activities
8,340
8,812
50,788
-3,438
Net change in cash
-27,861
-23,099
17,843
2,188
Cash at beginning of period
52,678
42,567
24,724
22,536
Cash at end of period
24,817
19,468
42,567
24,724
Free cash flow
Operating cash flow
-36,115
-31,845
-35,001
-28,166
Capital expenditure
-40
-66
-89
-
Free cash flow
-36,201
-31,911
-35,090
-28,166